Introduction Disordered voice quality could be a symptom of multiple sclerosis (MS). The impact of MS on voice-related quality of life is still controversial.
Objectives The aim of this study was to compare the results of voice self-assessment with the results of expert perceptual assessment in patients with MS.
Methods The research included 38 patients with relapse-remitting MS (23 women and 15 men; ages 21 to 83, mean = 44). All participants filled out a Voice Handicap Index (VHI), and their voice sample was analyzed by speech and language professionals using the Grade Roughness Breathiness Asthenia Strain scale (GRBAS).
Results The patients with MS had significantly higher VHI than control group participants (mean value 16.68 ± 16.2 compared with 5.29 ± 5.5, p = 0.0001). The study established a notable level of dysphonia in 55%, roughness and breathiness in 66%, asthenia in 34%, and strain in 55% of the vocal samples. A significant correlation was established between VHI and GRBAS scores (r = 0.3693, p = 0.0225), and VHI and asthenia and strain components (r = 0.4037 and 0.3775, p = 0.012 and 0.0195, respectively). The female group showed positive and significant correlation between claims for self-assessing one's voice (pVHI) and overall GRBAS scores, and between pVHI and grade, roughness, asthenia, and strain components. No significant correlation was found for male patients (p > 0.05).
Conclusion A significant number of patients with MS experienced voice problems. The VHI is a good and effective tool to assess patient self-perception of voice quality, but it may not reflect the severity of dysphonia as perceived by voice and speech professionals.
We present a case series of five patients who were diagnosed in our institution with rare tumors of neuroectodermal origin. They were discovered within 1 year, by two otorhinolaryngologists at the county hospital which covers the area of about 1,00,000 inhabitants. Neuroectodermal tumors of the head and neck are rare pathologies, with extremely varied clinical behavior, treatment and prognosis. The lack of symptom specificity, the low incidence of these tumors and the difficulties associated with histopathology are main reasons for delayed diagnosis and treatment. We point out that rare tumors, if considered individually, have a low incidence, some even negligible, but the pathology detected hundreds of types which increases the likelihood that we will encounter some of them in our practice. Second, the practice in medicine does not always follow the statistical and mathematical probabilities but should take into account less possible occurrences.
How to cite this article
Bauer V, Aleric Z, Jancic E, Bujas T. Rare Tumors of the Neuroectodermal Origin: Report of Five Cases. Int J Head Neck Surg 2012;3(2):108-111.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.